IONIS PHARMACEUTICALS INC's ticker is IONS and the CUSIP is 462222100. A total of 335 filers reported holding IONIS PHARMACEUTICALS INC in Q4 2022. The put-call ratio across all filers is 0.66 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $12,238 | -19.5% | 269,800 | -27.2% | 0.02% | -4.5% |
| Q2 2023 | $15,202 | -33.2% | 370,500 | -41.8% | 0.02% | -26.7% |
| Q1 2023 | $22,742 | -48.9% | 636,314 | -46.0% | 0.03% | -50.8% |
| Q4 2022 | $44,524 | -99.9% | 1,178,814 | +35.9% | 0.06% | +13.0% |
| Q3 2022 | $38,379,000 | +68.6% | 867,714 | +41.1% | 0.05% | +100.0% |
| Q2 2022 | $22,760,000 | +355.5% | 614,814 | +355.7% | 0.03% | +350.0% |
| Q1 2022 | $4,997,000 | -28.9% | 134,914 | -41.5% | 0.01% | -33.3% |
| Q4 2021 | $7,024,000 | +114.3% | 230,814 | +136.2% | 0.01% | +125.0% |
| Q3 2021 | $3,277,000 | -89.4% | 97,714 | -87.4% | 0.00% | -89.7% |
| Q2 2021 | $30,971,000 | +17.3% | 776,414 | +32.2% | 0.04% | +18.2% |
| Q1 2021 | $26,410,000 | -37.3% | 587,414 | -21.2% | 0.03% | -28.3% |
| Q4 2020 | $42,142,000 | -39.5% | 745,348 | -49.2% | 0.05% | -34.3% |
| Q3 2020 | $69,617,000 | -32.6% | 1,467,167 | -16.3% | 0.07% | -21.3% |
| Q2 2020 | $103,349,000 | +29.5% | 1,752,867 | +3.8% | 0.09% | +14.1% |
| Q1 2020 | $79,828,000 | -35.2% | 1,688,411 | -17.2% | 0.08% | -17.9% |
| Q4 2019 | $123,159,000 | +13.4% | 2,038,711 | +12.4% | 0.10% | +3.3% |
| Q3 2019 | $108,617,000 | -3.7% | 1,813,011 | +3.3% | 0.09% | -7.1% |
| Q2 2019 | $112,814,000 | +671.7% | 1,755,311 | +419.9% | 0.10% | +1137.5% |
| Q2 2018 | $14,618,000 | +45.6% | 337,628 | +48.3% | 0.01% | -27.3% |
| Q1 2018 | $10,038,000 | +139.5% | 227,714 | +176.3% | 0.01% | +120.0% |
| Q2 2017 | $4,192,000 | -66.7% | 82,414 | -73.7% | 0.01% | -72.2% |
| Q1 2017 | $12,591,000 | -41.4% | 313,214 | -30.3% | 0.02% | -47.1% |
| Q4 2016 | $21,500,000 | +113.5% | 449,514 | +63.6% | 0.03% | +88.9% |
| Q3 2016 | $10,069,000 | +136.1% | 274,814 | +50.1% | 0.02% | +125.0% |
| Q2 2016 | $4,264,000 | +77.2% | 183,100 | +208.2% | 0.01% | +60.0% |
| Q1 2016 | $2,406,000 | -71.3% | 59,400 | -56.1% | 0.01% | -72.2% |
| Q4 2015 | $8,380,000 | – | 135,314 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Tweedy, Browne Co LLC | 3,510,173 | $159,221,447 | 8.52% |
| Bellevue Group AG | 9,233,700 | $418,840,632 | 6.75% |
| Deep Track Capital, LP | 2,834,069 | $128,553,370 | 4.96% |
| BVF INC/IL | 4,004,613 | $181,649,246 | 4.90% |
| Sicart Associates LLC | 203,132 | $9,214,068 | 3.61% |
| Camber Capital Management LP | 2,250,000 | $102,060 | 3.36% |
| Privium Fund Management B.V. | 228,493 | $10,364,443 | 3.08% |
| Orbimed Advisors | 2,169,500 | $98,408,520 | 2.09% |
| SECTOR GAMMA AS | 165,616 | $7,512,342 | 1.92% |
| TANAKA CAPITAL MANAGEMENT INC | 14,612 | $663 | 1.89% |